Skip to main content

Table 1 Comparison of clinicopathological characteristics between high and low mGNRI groups in patients with pancreatic cancer

From: Modified geriatric nutritional risk index in patients with pancreatic cancer: a propensity score-matched analysis

  Before propensity score matching After propensity score matching
Characteristics High mGNRI group Low mGNRI group P-value High mGNRI group Low mGNRI group P-value
  (n = 91) (n = 46)   (n = 36) (n = 36)  
Age (years), median (range) 72 (47–85) 72.5 (44–85) 0.616 72.5 (55–85) 72.3 (44–85) 0.795
Sex (male), n (%) 51 (56%) 30 (65.2%) 0.302 20 (55.6%) 21 (58.3%) 0.812
Body mass index (kg/m2), median (range) 22.7 (18.8–32.5) 19.4 (13.7–29.4)  < 0.001 21.8 (18.9–30.0) 20.2 (13.7–28.5) 0.002
Tumor size (mm), median (range) 27.0 (11.0–85.0) 28.0 (5.0–60.0) 0.791 25.8 (11.0–85.0) 27.7 (5.0–60.0) 0.676
Tumor location (pancreatic head), n (%) 40 (44.0%) 16 (34.8%) 0.302 18 (50.0%) 14 (38.9%) 0.343
Histological grading (G2a or G3b), n (%) 42 (46.2%) 25 (54.3%) 0.365 18 (50.0%) 20 (55.6%) 0.637
Lymph node involvement (present), n (%) 44 (48.4%) 36 (78.3%) 0.001 26 (72.2%) 26 (72.2%) 1.000
Residual tumor (present), n (%) 10 (11.0%) 3 (6.5%) 0.543 3 (8.3%) 1 (2.8%) 0.614
ASA-PS (1 or 2, %) 78 (85.7%) 33 (71.7%) 0.065 31 (86.1%) 27 (75.0%) 0.234
Preoperative albumin, g/dL, median (range) 4.1 (2.6–4.9) 3.8 (2.1–4.9) 0.001 4.1 (3.3–4.8) 3.9 (2.7–4.9) 0.039
Preoperative lymphocyte count, median (range) 1640 (140–3800) 1405 (400–6660) 0.004 1740 (140–3016) 1389 (735–2496) 0.037
Preoperative CA19-9, U/mL, median (range) 53.3 (0.7–3270.7) 106.7 (0.7–3435.0) 0.121 58.9 (1.1–1591.6) 61.0 (0.7–1446.5) 0.875
Neoadjuvant chemotherapy (present), n (%) 15 (16.5%) 4 (8.7%) 0.297 2 (5.6%) 4 (11.1%) 0.674
Adjuvant chemotherapy (present), n (%) 52 (59.1%) 28 (60.9%) 0.842 23 (63.9%) 21 (58.3%) 0.629
  1. Continuous variables are expressed as the median and range
  2. mGNRI Modified geriatric nutritional risk index, ASA-PS American Society of Anesthesiologists physical status, CA19-9 Carbohydrate antigen 19–9
  3. aG2: moderately-differentiated
  4. bG3: poor-differentiated